[HTML][HTML] Risk of venous thromboembolism in transgender people undergoing hormone feminizing therapy: a prevalence meta-analysis and meta-regression study
M Totaro, S Palazzi, C Castellini, A Parisi… - Frontiers in …, 2021 - frontiersin.org
Background Although venous thromboembolism (VTE) is a recognized side effect of some
formulations of estrogen therapy, its impact in transgender people remains uncertain. The …
formulations of estrogen therapy, its impact in transgender people remains uncertain. The …
Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study
M Totaro, S Palazzi, C Castellini… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Although venous thromboembolism (VTE) is a recognized side effect of some
formulations of estrogen therapy, its impact in transgender people remains uncertain. The …
formulations of estrogen therapy, its impact in transgender people remains uncertain. The …
Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.
M Totaro, S Palazzi, C Castellini, A Parisi… - Frontiers in …, 2021 - europepmc.org
Background Although venous thromboembolism (VTE) is a recognized side effect of some
formulations of estrogen therapy, its impact in transgender people remains uncertain. The …
formulations of estrogen therapy, its impact in transgender people remains uncertain. The …
[HTML][HTML] Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression …
M Totaro, S Palazzi, C Castellini, A Parisi… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Background Although venous thromboembolism (VTE) is a recognized side effect of some
formulations of estrogen therapy, its impact in transgender people remains uncertain. The …
formulations of estrogen therapy, its impact in transgender people remains uncertain. The …